GSK upgraded to neutral at Credit Suisse on underperformance as Zantac concerns loom
Credit Suisse has upgraded GlaxoSmithKline (GSK) to underperform from neutral citing the company''s recent poor performance but adding that the pharma''s respiratory syncytial virus…
GSK upgraded to neutral at Credit Suisse on underperformance as Zantac concerns loom
Credit Suisse has upgraded GlaxoSmithKline (GSK) to underperform from neutral citing the company''s recent poor performance but adding that the pharma''s respiratory syncytial virus…